She recently (2015) moved to Chapman University School of Pharmacy, Irvine, CA from the University of Alberta, Canada where her group made important contributions in the fields of peptide-mimetics (beta-peptides), cancer targeting peptides (to increase the therapeutic index of current chemotherapeutic drugs), Glucosamine-peptide prodrugs (to increase the bioavailability of glucosamine) and class IIa bacteriocins (to develop diagnostics for pathogens and substitutes for conventional antibiotics). She has published 54 peer reviewed articles, 4 book chapters, been listed as an inventor in 1 approved patent, and has presented 23 invited talks. Anastasia Khvorova, Ph.D., Professor, Molecular Medicine, RNA Therapeutics Institute, University of Massachusetts Medical School